Methods for determining base locations in a polynucleotide

• US 10,760,117 B2
• Filed: 04/05/2016
• Issued: 09/01/2020
• Est. Priority Date: 04/06/2015
• Status: Active Grant

• Current Assignee: Regents of the University of California (University of California)
• Original Assignee: Regents of the University of California (University of California)
• Inventors: Jain, Miten, Olsen, Hugh Edward, Akeson, Mark A.
• Primary Examiner(s): Dauner, Joseph G.
• Application Number:
  US15/564,386
• Publication Number:
  US 20180258474A1
• Time in Patent Office: 1,610 Days
• CPC Class Codes: C12Q 1/6827 for detection of mutation or polymorphism
• CPC Class Codes: C12Q 1/6869 Methods for sequencing
• CPC Class Codes: C12Q 2521/531 Glycosylase
• CPC Class Codes: C12Q 2525/119 incorporating abasic sites
• CPC Class Codes: C12Q 2537/164 Methylation detection other then bisulfite or methylation sensitive restriction endonucleases
• CPC Class Codes: C12Q 2545/101 with an internal standard/control
• CPC Class Codes: C12Q 2563/116 electrical properties of nucleic acids, e.g. impedance, conductivity or resistance
• CPC Class Codes: C12Q 2565/631 being a biochannel or pore

Abstract

Disclosed are methods for polynucleotide sequencing that detect the location of selected nucleobases with greater precision. The methods can be used to determine the location and nature of modified bases in a polynucleotide, that is, non-canonical bases, or to improve accuracy of sequencing of “problem” regions of DNA sequencing such as homopolymers, GC rich areas, etc. The sequencing method exemplified is nanopore sequencing. Nanopore sequencing is used to generate a unique signal at a point in a polynucleotide sequence where an abasic site (AP site, or apurinic or apyrimidinic site) exists. As part of the method, an abasic site is specifically created enzymatically using a DNA glycosylase that recognizes a pre-determined nucleobase species and cleaves the N-glycosidic bond to release only that base, leaving an AP site in its place.

Claims

1. A method for detecting epigenetically modified cytosines in genomic DNA, wherein the epigenetically modified cytosines comprise 5-methylcytosine (5mC), 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC) and 5-carboxylcytosine (5caC), the method comprising:

(a) treating genomic DNA comprising or suspected of comprising the epigenetically modified cytosines with a 5-methylcytosine deaminase that acts on 5mC to create a T/U mismatch;

(b) treating the genomic DNA treated in (a) with a G/T(U) mismatch DNA glycosylase that acts on the T/U mismatch to create an abasic site in the genomic DNA; and

(c) conducting single molecule nanopore sequencing on the genomic DNA prepared in step (b), including determining a sequence that comprises the abasic site based on the ionic current of the abasic site, thereby detecting epigenetically modified cytosines in genomic DNA.

2. The method of claim 1, wherein the steps (a)-(c) are conducted on a first aliquot of the genomic DNA and the method further comprises:

(d) treating a second aliquot of the genomic DNA comprising or suspected of comprising the epigenetically modified cytosines with;

(i) a 5-methylcytosine DNA glycosylase that acts on 5mC to create an abasic site in the genomic DNA;

(ii) KRuO4 that acts on 5hmC to create 5fC, and further treating the genomic DNA treated in (d)(ii) with a thymine DNA glycosylase that acts on 5fC to create an abasic site in the genomic DNA, or

(iii) a thymine DNA glycosylase that acts on 5fC and 5caC to create an abasic site in the genomic DNA; and

(e) conducting single molecule nanopore sequencing on the genomic DNA prepared in step (d), including determining a sequence that comprises the abasic site based on the ionic current of the abasic site, thereby detecting epigenetically modified cytosines in the genomic DNA.

3. The method of claim 2, wherein the method comprises step (d)(i).

4. The method of claim 3, wherein the steps (a)-(c) are performed prior to steps (d)-(e) or simultaneously.

5. The method of claim 3, wherein the steps (d)-(e) are performed prior to steps (a)-(c) or simultaneously.

6. The method of claim 2, wherein the method comprises step (d)(ii).

7. The method of claim 6, wherein the steps (a)-(c) are performed prior to steps (d)-(e) or simultaneously.

8. The method of claim 6, wherein the steps (d)-(e) are performed prior to steps (a)-(c) or simultaneously.

9. The method of claim 2, wherein the method comprises step (d)(iii).

10. The method of claim 9, wherein the steps (a)-(c) are performed prior to steps (d)-(e) or simultaneously.

11. The method of claim 9, wherein the steps (d)-(e) are performed prior to steps (a)-(c) or simultaneously.

12. The method of claim 2, wherein the method comprises two or more of steps (d)(i)-(d)(iii), wherein the two or more steps are performed on separate aliquots of the genomic DNA.